Cargando…

A continued learning approach for model‐informed precision dosing: Updating models in clinical practice

Model‐informed precision dosing (MIPD) is a quantitative dosing framework that combines prior knowledge on the drug‐disease‐patient system with patient data from therapeutic drug/ biomarker monitoring (TDM) to support individualized dosing in ongoing treatment. Structural models and prior parameter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maier, Corinna, de Wiljes, Jana, Hartung, Niklas, Kloft, Charlotte, Huisinga, Wilhelm
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846635/ https://www.ncbi.nlm.nih.gov/pubmed/34779144 http://dx.doi.org/10.1002/psp4.12745

Ejemplares similares

Reinforcement learning and Bayesian data assimilation for model‐informed precision dosing in oncology
por: Maier, Corinna, et al.
Publicado: (2021)

Bayesian Data Assimilation to Support Informed Decision Making in Individualized Chemotherapy
por: Maier, Corinna, et al.
Publicado: (2020)

Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data
por: Kluwe, Franziska, et al.
Publicado: (2023)

Cell‐level systems biology model to study inflammatory bowel diseases and their treatment options
por: Stübler, Sabine, et al.
Publicado: (2023)

Deriving mechanism‐based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarin
por: Falkenhagen, Undine, et al.
Publicado: (2023)

Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing—A Translational Example for Intensive Care Units
por: Weinelt, Ferdinand Anton, et al.
Publicado: (2021)

Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study
por: Ehmann, Lisa, et al.
Publicado: (2017)

Nonparametric goodness‐of‐fit testing for parametric covariate models in pharmacometric analyses
por: Hartung, Niklas, et al.
Publicado: (2021)

A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non‐small cell lung cancer patients
por: Ojara, Francis Williams, et al.
Publicado: (2023)

C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework
por: Nassar, Yomna M., et al.
Publicado: (2023)

Physiology-based toxicokinetic modelling of aluminium in rat and man
por: Hethey, Christoph, et al.
Publicado: (2021)

Semimechanistic Clearance Models of Oncology Biotherapeutics and Impact of Study Design: Cetuximab as a Case Study
por: Grisic, Ana‐Marija, et al.
Publicado: (2020)

Continuous Learning in Model‐Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin
por: Hughes, Jasmine H., et al.
Publicado: (2020)

Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen
por: Klopp-Schulze, Lena, et al.
Publicado: (2020)

Nonlinear pharmacokinetics of therapeutic proteins resulting from receptor mediated endocytosis
por: Krippendorff, Ben-Fillippo, et al.
Publicado: (2009)

Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion
por: Nassar, Yomna M., et al.
Publicado: (2022)

Translational Pharmacometric Evaluation of Typical Antibiotic Broad‐Spectrum Combination Therapies Against Staphylococcus Aureus Exploiting In Vitro Information
por: Wicha, SG, et al.
Publicado: (2017)

Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients
por: Stachanow, Viktoria, et al.
Publicado: (2023)

Model-Informed Precision Dosing (MIPD)
por: Pérez-Blanco, Jonás Samuel, et al.
Publicado: (2022)

Editorial: Model-informed drug development and precision dosing in clinical pharmacology practice
por: Hu, Ke, et al.
Publicado: (2023)

Model-informed precision dosing in vancomycin treatment
por: Yoon, Sukyong, et al.
Publicado: (2023)

Exploring Dried Blood Spot Cortisol Concentrations as an Alternative for Monitoring Pediatric Adrenal Insufficiency Patients: A Model-Based Analysis
por: Stachanow, Viktoria, et al.
Publicado: (2022)

Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients
por: Busse, David, et al.
Publicado: (2021)

Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies
por: Mueller-Schoell, Anna, et al.
Publicado: (2021)

Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups
por: Mueller-Schoell, Anna, et al.
Publicado: (2021)

Model-Informed Precision Dosing of Antibiotics in Osteoarticular Infections
por: Liu, Lingling, et al.
Publicado: (2022)

Which Analysis Approach Is Adequate to Leverage Clinical Microdialysis Data? A Quantitative Comparison to Investigate Exposure and Response Exemplified by Levofloxacin
por: Busse, David, et al.
Publicado: (2021)

Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
por: Démaris, Alix, et al.
Publicado: (2022)

Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model
por: Mueller-Schoell, Anna, et al.
Publicado: (2021)

Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
por: Schatz, Lea Marie, et al.
Publicado: (2023)

Model‐Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities
por: Keizer, Ron J., et al.
Publicado: (2018)

2539. Towards Biomarker-Guided Model Informed Precision Dosing – A Case Study With Continuously Infused Vancomycin in Sepsis
por: Ermtraud, Julian, et al.
Publicado: (2023)

Precision sirolimus dosing in children: The potential for model-informed dosing and novel drug monitoring
por: Shen, Guofang, et al.
Publicado: (2023)

Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis
por: Mockeliunas, Laurynas, et al.
Publicado: (2022)

The Dirichlet Dual Response Model: An Item Response Model for Continuous Bounded Interval Responses
por: Kloft, Matthias, et al.
Publicado: (2023)

Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools
por: Weinelt, Ferdinand Anton, et al.
Publicado: (2022)

Quantifying uncertainty, variability and likelihood for ordinary differential equation models
por: Weiße, Andrea Y, et al.
Publicado: (2010)

Impact of Inaccurate Documentation of Sampling and Infusion Time in Model-Informed Precision Dosing
por: Alihodzic, Dzenefa, et al.
Publicado: (2020)

Model-Informed Precision Dosing of Antibiotics in Pediatric Patients: A Narrative Review
por: Abdulla, Alan, et al.
Publicado: (2021)

A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
por: van Beek, Stijn W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_egn502sp6a4cq1udc5k8cp65p4